SPRY2 and hepatocellular carcinoma: In conclusion, by directly repressing CBL, miR-22-3p decreases the ubiquitination of SPRY2 and stabilizes it, which inhibits the EMT, migration/invasion, and CSC characteristics of HCC cells.